Daniela Annibali

13PUBLICATIONS
144CO-AUTHORS
Predictive and prognostic markersMolecular targetsPsychosocial aspects of childbirth and perinatal mental healthNutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State.

Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba

|May 07, 2024
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.

Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts

|Jul 14, 2023
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Hanne Lefrère, Kat Moore, Giuseppe Floris

|Aug 05, 2022
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers.

Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld

|Oct 19, 2021
Nuclear PHGDH protects cancer cells from nutrient stress.

Daniela Annibali, Sarah-Maria Fendt

|Aug 27, 2021
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?

Regina Esi Mensimah Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts

Pageof 3

Frequent Collaborators

5 joint publications

Frederic Amant

3 joint publications

Diether Lambrechts

3 joint publications

Lingeng Lu

3 joint publications

Todd Edwards